552 related articles for article (PubMed ID: 19640926)
1. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
Alegre-Abarrategui J; Christian H; Lufino MM; Mutihac R; Venda LL; Ansorge O; Wade-Martins R
Hum Mol Genet; 2009 Nov; 18(21):4022-34. PubMed ID: 19640926
[TBL] [Abstract][Full Text] [Related]
2. Parkinson disease, LRRK2 and the endocytic-autophagic pathway.
Alegre-Abarrategui J; Wade-Martins R
Autophagy; 2009 Nov; 5(8):1208-10. PubMed ID: 19770575
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.
Nichols RJ; Dzamko N; Morrice NA; Campbell DG; Deak M; Ordureau A; Macartney T; Tong Y; Shen J; Prescott AR; Alessi DR
Biochem J; 2010 Sep; 430(3):393-404. PubMed ID: 20642453
[TBL] [Abstract][Full Text] [Related]
4. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
Plowey ED; Cherra SJ; Liu YJ; Chu CT
J Neurochem; 2008 May; 105(3):1048-56. PubMed ID: 18182054
[TBL] [Abstract][Full Text] [Related]
5. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
Niu J; Yu M; Wang C; Xu Z
J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 transport is regulated by its novel interacting partner Rab32.
Waschbüsch D; Michels H; Strassheim S; Ossendorf E; Kessler D; Gloeckner CJ; Barnekow A
PLoS One; 2014; 9(10):e111632. PubMed ID: 25360523
[TBL] [Abstract][Full Text] [Related]
7. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells.
Fader CM; Sánchez D; Furlán M; Colombo MI
Traffic; 2008 Feb; 9(2):230-50. PubMed ID: 17999726
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LRRK2 kinase activity stimulates macroautophagy.
Manzoni C; Mamais A; Dihanich S; Abeti R; Soutar MPM; Plun-Favreau H; Giunti P; Tooze SA; Bandopadhyay R; Lewis PA
Biochim Biophys Acta; 2013 Dec; 1833(12):2900-2910. PubMed ID: 23916833
[TBL] [Abstract][Full Text] [Related]
9.
Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
[TBL] [Abstract][Full Text] [Related]
10. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.
Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R
Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.
Gómez-Suaga P; Rivero-Ríos P; Fdez E; Blanca Ramírez M; Ferrer I; Aiastui A; López De Munain A; Hilfiker S
Hum Mol Genet; 2014 Dec; 23(25):6779-96. PubMed ID: 25080504
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2.
Tong Y; Shen J
Biochem Soc Trans; 2012 Oct; 40(5):1042-6. PubMed ID: 22988862
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.
Greene ID; Mastaglia F; Meloni BP; West KA; Chieng J; Mitchell CJ; Gai WP; Boulos S
J Neurosci Res; 2014 Apr; 92(4):506-16. PubMed ID: 24375786
[TBL] [Abstract][Full Text] [Related]
14. Leucine-rich repeat kinase 2 associates with lipid rafts.
Hatano T; Kubo S; Imai S; Maeda M; Ishikawa K; Mizuno Y; Hattori N
Hum Mol Genet; 2007 Mar; 16(6):678-90. PubMed ID: 17341485
[TBL] [Abstract][Full Text] [Related]
15. Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway.
Tong Y; Giaime E; Yamaguchi H; Ichimura T; Liu Y; Si H; Cai H; Bonventre JV; Shen J
Mol Neurodegener; 2012 Jan; 7():2. PubMed ID: 22230652
[TBL] [Abstract][Full Text] [Related]
16. Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.
Sanstrum BJ; Goo BMSS; Holden DZY; Delgado DD; Nguyen TPN; Lee KD; James NG
Molecules; 2020 May; 25(11):. PubMed ID: 32486414
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation.
Manzoni C; Mamais A; Dihanich S; McGoldrick P; Devine MJ; Zerle J; Kara E; Taanman JW; Healy DG; Marti-Masso JF; Schapira AH; Plun-Favreau H; Tooze S; Hardy J; Bandopadhyay R; Lewis PA
Biochem Biophys Res Commun; 2013 Nov; 441(4):862-6. PubMed ID: 24211199
[TBL] [Abstract][Full Text] [Related]
18. The R1441C mutation of LRRK2 disrupts GTP hydrolysis.
Lewis PA; Greggio E; Beilina A; Jain S; Baker A; Cookson MR
Biochem Biophys Res Commun; 2007 Jun; 357(3):668-71. PubMed ID: 17442267
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 interferes with aggresome formation for autophagic clearance.
Bang Y; Kim KS; Seol W; Choi HJ
Mol Cell Neurosci; 2016 Sep; 75():71-80. PubMed ID: 27364102
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization.
Dzamko N; Deak M; Hentati F; Reith AD; Prescott AR; Alessi DR; Nichols RJ
Biochem J; 2010 Sep; 430(3):405-13. PubMed ID: 20659021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
